Retrospective Analysis Evaluating Molecular Factors of Primary Resistance to Tyrosine Kinase Inhibitors in Metastatic Non Small Cell Lung Cancer Patients
Non small cell lung cancer patients.
Observational Model: Cohort, Time Perspective: Retrospective
Determine the incidence of EGFR (Epidermal growth factor ) and KRAS (Kirsten ras sarcoma viral oncogene homolog ) mutations in 300 NSCLC (non small cell lung cancer) patients treated with gefitinib or erlotinib
Armando Santoro, MD
Istituto Clinico Humanitas
Italy: Ministry of Health